Intuitive Surgical, Inc. $ISRG Holdings Increased by BNP Paribas

BNP Paribas increased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 7.3% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 31,694 shares of the medical equipment provider’s stock after buying an additional 2,153 shares during the period. BNP Paribas’ holdings in Intuitive Surgical were worth $12,888,000 at the end of the most recent reporting period.

A number of other institutional investors also recently added to or reduced their stakes in ISRG. Bank of America Corp DE increased its holdings in shares of Intuitive Surgical by 3.3% in the 1st quarter. Bank of America Corp DE now owns 3,616,973 shares of the medical equipment provider’s stock valued at $1,667,388,000 after acquiring an additional 116,292 shares during the last quarter. Bank of New York Mellon Corp acquired a new position in Intuitive Surgical in the second quarter valued at approximately $1,335,753,000. Amundi boosted its holdings in Intuitive Surgical by 8.6% in the first quarter. Amundi now owns 2,428,356 shares of the medical equipment provider’s stock valued at $1,119,448,000 after purchasing an additional 193,096 shares in the last quarter. Sumitomo Mitsui Trust Group Inc. increased its stake in Intuitive Surgical by 10.8% in the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,893,485 shares of the medical equipment provider’s stock valued at $769,948,000 after purchasing an additional 184,044 shares during the last quarter. Finally, Janus Henderson Group PLC raised its holdings in Intuitive Surgical by 3.7% during the first quarter. Janus Henderson Group PLC now owns 1,643,060 shares of the medical equipment provider’s stock worth $757,489,000 after purchasing an additional 58,587 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Trading Down 2.0%

NASDAQ:ISRG opened at $399.06 on Friday. The firm has a market cap of $138.33 billion, a price-to-earnings ratio of 48.25, a price-to-earnings-growth ratio of 2.75 and a beta of 1.45. The company’s 50-day moving average is $423.51 and its two-hundred day moving average is $427.91. Intuitive Surgical, Inc. has a 12-month low of $328.57 and a 12-month high of $603.88.

Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last announced its quarterly earnings data on Tuesday, October 20th. The medical equipment provider reported $3.00 EPS for the quarter, beating analysts’ consensus estimates of $2.65 by $0.35. The business had revenue of $3.05 billion during the quarter, compared to the consensus estimate of $2.91 billion. Intuitive Surgical had a return on equity of 18.17% and a net margin of 25.54%. The business’s revenue for the quarter was up 21.7% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.40 earnings per share. On average, equities research analysts forecast that Intuitive Surgical, Inc. will post 9.37 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, Director Craig Barratt sold 1,150 shares of the stock in a transaction on Wednesday, November 4th. The stock was sold at an average price of $460.00, for a total value of $529,000.00. Following the completion of the sale, the director directly owned 1,150 shares in the company, valued at approximately $529,000. This represents a 50.00% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gary Guthart sold 20,095 shares of the firm’s stock in a transaction dated Friday, October 23rd. The shares were sold at an average price of $451.61, for a total value of $9,075,102.95. Following the completion of the transaction, the director directly owned 1,204,530 shares in the company, valued at $543,977,793.30. This trade represents a 1.64% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 39,363 shares of company stock worth $17,738,749. 0.60% of the stock is owned by company insiders.

Intuitive Surgical News Summary

These are some of the ISRG news items that stood out recently:

  • Positive Sentiment: A BTIG Research analyst reportedly expects ISRG shares to rise, providing a positive analyst signal; the headline does not specify a price target or the reasoning. BTIG analyst article
  • Neutral Sentiment: Options-market coverage notes activity that investors may want to watch, but provides no clear directional conclusion or confirmed catalyst. Options-market article
  • Negative Sentiment: ISRG was reported down 1.7% since its latest earnings report, suggesting the strong results have not yet translated into sustained share-price momentum. The article offers no fresh earnings-estimate change to clarify the potential for a rebound. Post-earnings performance article

Analyst Ratings Changes

Several research analysts have recently issued reports on ISRG shares. BNP Paribas Exane upgraded shares of Intuitive Surgical to an “outperform” rating in a report on Tuesday, July 28th. Zacks Research upgraded Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a research report on Thursday, October 22nd. Robert W. Baird boosted their target price on Intuitive Surgical from $513.00 to $550.00 and gave the company an “outperform” rating in a report on Wednesday, October 21st. Wall Street Zen raised Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Saturday, October 31st. Finally, Raymond James Financial restated an “outperform” rating and set a $480.00 price target on shares of Intuitive Surgical in a research note on Wednesday, October 21st. One investment analyst has rated the stock with a Strong Buy rating, twenty-three have assigned a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $495.90.

Get Our Latest Report on Intuitive Surgical

Intuitive Surgical Profile

(Free Report)

Intuitive Surgical develops, manufactures and markets robotic-assisted systems for minimally invasive procedures. Its products include da Vinci surgical systems, which allow surgeons to control instruments and a high-definition vision system from a console, as well as the Ion endoluminal system, designed to assist with minimally invasive lung biopsies. The company also provides instruments, accessories, training and support services for its systems. Its technology is used in a range of surgical specialties, including urology, general surgery and gynecology.

Featured Articles

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.